http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009311719-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 |
filingDate | 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb6ab5493912e18b5d05867eb1afb93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a4c015349d93d562c81c66ac7ac7bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91340286c8d969ab7586cff9bf0f7719 |
publicationDate | 2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2009311719-A1 |
titleOfInvention | In vitro method for diagnosing neurodegenerative diseases |
abstract | Disclosed is an in vitro method for the detection, for the determination of the severity and for the assessment of the progress and prediction of neurodegenerative diseases, in which the presence and/or concentration of carbamoyl phosphate synthetase 1 (CPS 1) is determined in a biological fluid of a patient who suffers from a neurodegenerative disease or is suspected of suffering from such a disease, and conclusions about the presence, progression, severity or success of a treatment of the neurodegenerative disease are drawn on the basis of the determined presence and/or concentration of CPS 1 or the non-detectability of a CPS 1 immune reactivity. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008126119-A1 |
priorityDate | 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.